Request Deal Involvement

US WorldMeds to acquire four cell therapy assets from Adaptimmune for $55m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Ropes & Gray

legal advisors

Ropes & Gray

TD Cowen

financial advisors

TD Cowen

Oaktree Capital Management

debt providers

Oaktree Capital Management

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Athyrium Capital Management

debt providers

Athyrium Capital Management

Sullivan & Cromwell

legal advisors to debt providers

Sullivan & Cromwell

or

Principals

ADAPTIMMUNE [FOUR CELL THERAPY ASSETS]

target

ADAPTIMMUNE [FOUR CELL THERAPY ASSETS]

ADAPTIMMUNE THERAPEUTICS PLC

vendor

ADAPTIMMUNE THERAPEUTICS PLC

US WORLDMEDS

bidder

US WORLDMEDS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite